Global Human Insulin Market Insights and Forecast to 2028

Global Human Insulin Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Human Insulin Product Introduction
1.2 Market by Type
1.2.1 Global Human Insulin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Insulin Analogs and Biosimilars
1.2.3 Human Insulin Biologics
1.3 Market by Application
1.3.1 Global Human Insulin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Short Acting
1.3.3 Intermediate Acting
1.3.4 Long Acting
1.3.5 Pre-Mix Insulin
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Insulin Sales Estimates and Forecasts 2017-2028
2.2 Global Human Insulin Revenue Estimates and Forecasts 2017-2028
2.3 Global Human Insulin Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Human Insulin Sales by Region
2.4.1 Global Human Insulin Sales by Region (2017-2022)
2.4.2 Global Sales Human Insulin by Region (2023-2028)
2.5 Global Human Insulin Revenue by Region
2.5.1 Global Human Insulin Revenue by Region (2017-2022)
2.5.2 Global Human Insulin Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Human Insulin Sales by Manufacturers
3.1.1 Global Top Human Insulin Manufacturers by Sales (2017-2022)
3.1.2 Global Human Insulin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Insulin in 2021
3.2 Global Human Insulin Revenue by Manufacturers
3.2.1 Global Human Insulin Revenue by Manufacturers (2017-2022)
3.2.2 Global Human Insulin Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Human Insulin Revenue in 2021
3.3 Global Human Insulin Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Human Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Human Insulin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Human Insulin Sales by Type
4.1.1 Global Human Insulin Historical Sales by Type (2017-2022)
4.1.2 Global Human Insulin Forecasted Sales by Type (2023-2028)
4.1.3 Global Human Insulin Sales Market Share by Type (2017-2028)
4.2 Global Human Insulin Revenue by Type
4.2.1 Global Human Insulin Historical Revenue by Type (2017-2022)
4.2.2 Global Human Insulin Forecasted Revenue by Type (2023-2028)
4.2.3 Global Human Insulin Revenue Market Share by Type (2017-2028)
4.3 Global Human Insulin Price by Type
4.3.1 Global Human Insulin Price by Type (2017-2022)
4.3.2 Global Human Insulin Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Human Insulin Sales by Application
5.1.1 Global Human Insulin Historical Sales by Application (2017-2022)
5.1.2 Global Human Insulin Forecasted Sales by Application (2023-2028)
5.1.3 Global Human Insulin Sales Market Share by Application (2017-2028)
5.2 Global Human Insulin Revenue by Application
5.2.1 Global Human Insulin Historical Revenue by Application (2017-2022)
5.2.2 Global Human Insulin Forecasted Revenue by Application (2023-2028)
5.2.3 Global Human Insulin Revenue Market Share by Application (2017-2028)
5.3 Global Human Insulin Price by Application
5.3.1 Global Human Insulin Price by Application (2017-2022)
5.3.2 Global Human Insulin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Human Insulin Market Size by Type
6.1.1 North America Human Insulin Sales by Type (2017-2028)
6.1.2 North America Human Insulin Revenue by Type (2017-2028)
6.2 North America Human Insulin Market Size by Application
6.2.1 North America Human Insulin Sales by Application (2017-2028)
6.2.2 North America Human Insulin Revenue by Application (2017-2028)
6.3 North America Human Insulin Market Size by Country
6.3.1 North America Human Insulin Sales by Country (2017-2028)
6.3.2 North America Human Insulin Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Human Insulin Market Size by Type
7.1.1 Europe Human Insulin Sales by Type (2017-2028)
7.1.2 Europe Human Insulin Revenue by Type (2017-2028)
7.2 Europe Human Insulin Market Size by Application
7.2.1 Europe Human Insulin Sales by Application (2017-2028)
7.2.2 Europe Human Insulin Revenue by Application (2017-2028)
7.3 Europe Human Insulin Market Size by Country
7.3.1 Europe Human Insulin Sales by Country (2017-2028)
7.3.2 Europe Human Insulin Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Human Insulin Market Size by Type
8.1.1 Asia Pacific Human Insulin Sales by Type (2017-2028)
8.1.2 Asia Pacific Human Insulin Revenue by Type (2017-2028)
8.2 Asia Pacific Human Insulin Market Size by Application
8.2.1 Asia Pacific Human Insulin Sales by Application (2017-2028)
8.2.2 Asia Pacific Human Insulin Revenue by Application (2017-2028)
8.3 Asia Pacific Human Insulin Market Size by Region
8.3.1 Asia Pacific Human Insulin Sales by Region (2017-2028)
8.3.2 Asia Pacific Human Insulin Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Human Insulin Market Size by Type
9.1.1 Latin America Human Insulin Sales by Type (2017-2028)
9.1.2 Latin America Human Insulin Revenue by Type (2017-2028)
9.2 Latin America Human Insulin Market Size by Application
9.2.1 Latin America Human Insulin Sales by Application (2017-2028)
9.2.2 Latin America Human Insulin Revenue by Application (2017-2028)
9.3 Latin America Human Insulin Market Size by Country
9.3.1 Latin America Human Insulin Sales by Country (2017-2028)
9.3.2 Latin America Human Insulin Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Human Insulin Market Size by Type
10.1.1 Middle East and Africa Human Insulin Sales by Type (2017-2028)
10.1.2 Middle East and Africa Human Insulin Revenue by Type (2017-2028)
10.2 Middle East and Africa Human Insulin Market Size by Application
10.2.1 Middle East and Africa Human Insulin Sales by Application (2017-2028)
10.2.2 Middle East and Africa Human Insulin Revenue by Application (2017-2028)
10.3 Middle East and Africa Human Insulin Market Size by Country
10.3.1 Middle East and Africa Human Insulin Sales by Country (2017-2028)
10.3.2 Middle East and Africa Human Insulin Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 B. Braun
11.1.1 B. Braun Corporation Information
11.1.2 B. Braun Overview
11.1.3 B. Braun Human Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 B. Braun Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 B. Braun Recent Developments
11.2 Becton, Dickinson
11.2.1 Becton, Dickinson Corporation Information
11.2.2 Becton, Dickinson Overview
11.2.3 Becton, Dickinson Human Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Becton, Dickinson Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Becton, Dickinson Recent Developments
11.3 Biocon
11.3.1 Biocon Corporation Information
11.3.2 Biocon Overview
11.3.3 Biocon Human Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Biocon Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Biocon Recent Developments
11.4 Biodel
11.4.1 Biodel Corporation Information
11.4.2 Biodel Overview
11.4.3 Biodel Human Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Biodel Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Biodel Recent Developments
11.5 ELI Lilly
11.5.1 ELI Lilly Corporation Information
11.5.2 ELI Lilly Overview
11.5.3 ELI Lilly Human Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 ELI Lilly Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 ELI Lilly Recent Developments
11.6 Julphar
11.6.1 Julphar Corporation Information
11.6.2 Julphar Overview
11.6.3 Julphar Human Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Julphar Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Julphar Recent Developments
11.7 NOVO Nordisk
11.7.1 NOVO Nordisk Corporation Information
11.7.2 NOVO Nordisk Overview
11.7.3 NOVO Nordisk Human Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 NOVO Nordisk Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 NOVO Nordisk Recent Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Overview
11.8.3 Sanofi Human Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sanofi Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sanofi Recent Developments
11.9 Wockhardt
11.9.1 Wockhardt Corporation Information
11.9.2 Wockhardt Overview
11.9.3 Wockhardt Human Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Wockhardt Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Wockhardt Recent Developments
11.10 Ypsomed
11.10.1 Ypsomed Corporation Information
11.10.2 Ypsomed Overview
11.10.3 Ypsomed Human Insulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Ypsomed Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Ypsomed Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Human Insulin Industry Chain Analysis
12.2 Human Insulin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Insulin Production Mode & Process
12.4 Human Insulin Sales and Marketing
12.4.1 Human Insulin Sales Channels
12.4.2 Human Insulin Distributors
12.5 Human Insulin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Human Insulin Industry Trends
13.2 Human Insulin Market Drivers
13.3 Human Insulin Market Challenges
13.4 Human Insulin Market Restraints
14 Key Findings in The Global Human Insulin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Human Insulin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Insulin Analogs and Biosimilars
Table 3. Major Manufacturers of Human Insulin Biologics
Table 4. Global Human Insulin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Human Insulin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Human Insulin Sales by Region (2017-2022) & (K Doses)
Table 7. Global Human Insulin Sales Market Share by Region (2017-2022)
Table 8. Global Human Insulin Sales by Region (2023-2028) & (K Doses)
Table 9. Global Human Insulin Sales Market Share by Region (2023-2028)
Table 10. Global Human Insulin Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Human Insulin Revenue Market Share by Region (2017-2022)
Table 12. Global Human Insulin Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Human Insulin Revenue Market Share by Region (2023-2028)
Table 14. Global Human Insulin Sales by Manufacturers (2017-2022) & (K Doses)
Table 15. Global Human Insulin Sales Share by Manufacturers (2017-2022)
Table 16. Global Human Insulin Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Human Insulin Revenue Share by Manufacturers (2017-2022)
Table 18. Human Insulin Price by Manufacturers (2017-2022) &(USD/Dose)
Table 19. Global Human Insulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Human Insulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Insulin as of 2021)
Table 21. Human Insulin Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Human Insulin Product Offered
Table 23. Date of Manufacturers Enter into Human Insulin Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Human Insulin Sales by Type (2017-2022) & (K Doses)
Table 26. Global Human Insulin Sales by Type (2023-2028) & (K Doses)
Table 27. Global Human Insulin Sales Share by Type (2017-2022)
Table 28. Global Human Insulin Sales Share by Type (2023-2028)
Table 29. Global Human Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Human Insulin Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Human Insulin Revenue Share by Type (2017-2022)
Table 32. Global Human Insulin Revenue Share by Type (2023-2028)
Table 33. Human Insulin Price by Type (2017-2022) & (USD/Dose)
Table 34. Global Human Insulin Price Forecast by Type (2023-2028) & (USD/Dose)
Table 35. Global Human Insulin Sales by Application (2017-2022) & (K Doses)
Table 36. Global Human Insulin Sales by Application (2023-2028) & (K Doses)
Table 37. Global Human Insulin Sales Share by Application (2017-2022)
Table 38. Global Human Insulin Sales Share by Application (2023-2028)
Table 39. Global Human Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Human Insulin Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Human Insulin Revenue Share by Application (2017-2022)
Table 42. Global Human Insulin Revenue Share by Application (2023-2028)
Table 43. Human Insulin Price by Application (2017-2022) & (USD/Dose)
Table 44. Global Human Insulin Price Forecast by Application (2023-2028) & (USD/Dose)
Table 45. North America Human Insulin Sales by Type (2017-2022) & (K Doses)
Table 46. North America Human Insulin Sales by Type (2023-2028) & (K Doses)
Table 47. North America Human Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Human Insulin Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Human Insulin Sales by Application (2017-2022) & (K Doses)
Table 50. North America Human Insulin Sales by Application (2023-2028) & (K Doses)
Table 51. North America Human Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Human Insulin Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Human Insulin Sales by Country (2017-2022) & (K Doses)
Table 54. North America Human Insulin Sales by Country (2023-2028) & (K Doses)
Table 55. North America Human Insulin Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Human Insulin Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Human Insulin Sales by Type (2017-2022) & (K Doses)
Table 58. Europe Human Insulin Sales by Type (2023-2028) & (K Doses)
Table 59. Europe Human Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Human Insulin Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Human Insulin Sales by Application (2017-2022) & (K Doses)
Table 62. Europe Human Insulin Sales by Application (2023-2028) & (K Doses)
Table 63. Europe Human Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Human Insulin Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Human Insulin Sales by Country (2017-2022) & (K Doses)
Table 66. Europe Human Insulin Sales by Country (2023-2028) & (K Doses)
Table 67. Europe Human Insulin Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Human Insulin Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Human Insulin Sales by Type (2017-2022) & (K Doses)
Table 70. Asia Pacific Human Insulin Sales by Type (2023-2028) & (K Doses)
Table 71. Asia Pacific Human Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Human Insulin Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Human Insulin Sales by Application (2017-2022) & (K Doses)
Table 74. Asia Pacific Human Insulin Sales by Application (2023-2028) & (K Doses)
Table 75. Asia Pacific Human Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Human Insulin Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Human Insulin Sales by Region (2017-2022) & (K Doses)
Table 78. Asia Pacific Human Insulin Sales by Region (2023-2028) & (K Doses)
Table 79. Asia Pacific Human Insulin Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Human Insulin Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Human Insulin Sales by Type (2017-2022) & (K Doses)
Table 82. Latin America Human Insulin Sales by Type (2023-2028) & (K Doses)
Table 83. Latin America Human Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Human Insulin Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Human Insulin Sales by Application (2017-2022) & (K Doses)
Table 86. Latin America Human Insulin Sales by Application (2023-2028) & (K Doses)
Table 87. Latin America Human Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Human Insulin Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Human Insulin Sales by Country (2017-2022) & (K Doses)
Table 90. Latin America Human Insulin Sales by Country (2023-2028) & (K Doses)
Table 91. Latin America Human Insulin Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Human Insulin Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Human Insulin Sales by Type (2017-2022) & (K Doses)
Table 94. Middle East and Africa Human Insulin Sales by Type (2023-2028) & (K Doses)
Table 95. Middle East and Africa Human Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Human Insulin Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Human Insulin Sales by Application (2017-2022) & (K Doses)
Table 98. Middle East and Africa Human Insulin Sales by Application (2023-2028) & (K Doses)
Table 99. Middle East and Africa Human Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Human Insulin Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Human Insulin Sales by Country (2017-2022) & (K Doses)
Table 102. Middle East and Africa Human Insulin Sales by Country (2023-2028) & (K Doses)
Table 103. Middle East and Africa Human Insulin Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Human Insulin Revenue by Country (2023-2028) & (US$ Million)
Table 105. B. Braun Corporation Information
Table 106. B. Braun Description and Major Businesses
Table 107. B. Braun Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 108. B. Braun Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. B. Braun Recent Developments
Table 110. Becton, Dickinson Corporation Information
Table 111. Becton, Dickinson Description and Major Businesses
Table 112. Becton, Dickinson Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 113. Becton, Dickinson Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Becton, Dickinson Recent Developments
Table 115. Biocon Corporation Information
Table 116. Biocon Description and Major Businesses
Table 117. Biocon Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 118. Biocon Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Biocon Recent Developments
Table 120. Biodel Corporation Information
Table 121. Biodel Description and Major Businesses
Table 122. Biodel Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 123. Biodel Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Biodel Recent Developments
Table 125. ELI Lilly Corporation Information
Table 126. ELI Lilly Description and Major Businesses
Table 127. ELI Lilly Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 128. ELI Lilly Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. ELI Lilly Recent Developments
Table 130. Julphar Corporation Information
Table 131. Julphar Description and Major Businesses
Table 132. Julphar Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 133. Julphar Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Julphar Recent Developments
Table 135. NOVO Nordisk Corporation Information
Table 136. NOVO Nordisk Description and Major Businesses
Table 137. NOVO Nordisk Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 138. NOVO Nordisk Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. NOVO Nordisk Recent Developments
Table 140. Sanofi Corporation Information
Table 141. Sanofi Description and Major Businesses
Table 142. Sanofi Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 143. Sanofi Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Sanofi Recent Developments
Table 145. Wockhardt Corporation Information
Table 146. Wockhardt Description and Major Businesses
Table 147. Wockhardt Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 148. Wockhardt Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Wockhardt Recent Developments
Table 150. Ypsomed Corporation Information
Table 151. Ypsomed Description and Major Businesses
Table 152. Ypsomed Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 153. Ypsomed Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Ypsomed Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Human Insulin Distributors List
Table 158. Human Insulin Customers List
Table 159. Human Insulin Market Trends
Table 160. Human Insulin Market Drivers
Table 161. Human Insulin Market Challenges
Table 162. Human Insulin Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Insulin Product Picture
Figure 3. Global Human Insulin Market Share by Type in 2021 & 2028
Figure 3. Insulin Analogs and Biosimilars Product Picture
Figure 4. Human Insulin Biologics Product Picture
Figure 5. Global Human Insulin Market Share by Application in 2021 & 2028
Figure 6. Short Acting
Figure 7. Intermediate Acting
Figure 8. Long Acting
Figure 9. Pre-Mix Insulin
Figure 10. Human Insulin Report Years Considered
Figure 11. Global Human Insulin Sales 2017-2028 (K Doses)
Figure 12. Global Human Insulin Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Human Insulin Revenue 2017-2028 (US$ Million)
Figure 14. Global Human Insulin Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Human Insulin Sales Market Share by Region (2017-2022)
Figure 16. Global Human Insulin Sales Market Share by Region (2023-2028)
Figure 17. North America Human Insulin Sales YoY (2017-2028) & (K Doses)
Figure 18. North America Human Insulin Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Human Insulin Sales YoY (2017-2028) & (K Doses)
Figure 20. Europe Human Insulin Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Human Insulin Sales YoY (2017-2028) & (K Doses)
Figure 22. Asia-Pacific Human Insulin Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Human Insulin Sales YoY (2017-2028) & (K Doses)
Figure 24. Latin America Human Insulin Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Human Insulin Sales YoY (2017-2028) & (K Doses)
Figure 26. Middle East & Africa Human Insulin Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Human Insulin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Human Insulin in the World: Market Share by Human Insulin Revenue in 2021
Figure 29. Global Human Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Human Insulin Sales Market Share by Type (2017-2028)
Figure 31. Global Human Insulin Revenue Market Share by Type (2017-2028)
Figure 32. Global Human Insulin Sales Market Share by Application (2017-2028)
Figure 33. Global Human Insulin Revenue Market Share by Application (2017-2028)
Figure 34. North America Human Insulin Sales Market Share by Type (2017-2028)
Figure 35. North America Human Insulin Revenue Market Share by Type (2017-2028)
Figure 36. North America Human Insulin Sales Market Share by Application (2017-2028)
Figure 37. North America Human Insulin Revenue Market Share by Application (2017-2028)
Figure 38. North America Human Insulin Sales Share by Country (2017-2028)
Figure 39. North America Human Insulin Revenue Share by Country (2017-2028)
Figure 40. U.S. Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Human Insulin Sales Market Share by Type (2017-2028)
Figure 43. Europe Human Insulin Revenue Market Share by Type (2017-2028)
Figure 44. Europe Human Insulin Sales Market Share by Application (2017-2028)
Figure 45. Europe Human Insulin Revenue Market Share by Application (2017-2028)
Figure 46. Europe Human Insulin Sales Share by Country (2017-2028)
Figure 47. Europe Human Insulin Revenue Share by Country (2017-2028)
Figure 48. Germany Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 49. France Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Human Insulin Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Human Insulin Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Human Insulin Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Human Insulin Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Human Insulin Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Human Insulin Revenue Share by Region (2017-2028)
Figure 59. China Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 62. India Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Human Insulin Sales Market Share by Type (2017-2028)
Figure 70. Latin America Human Insulin Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Human Insulin Sales Market Share by Application (2017-2028)
Figure 72. Latin America Human Insulin Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Human Insulin Sales Share by Country (2017-2028)
Figure 74. Latin America Human Insulin Revenue Share by Country (2017-2028)
Figure 75. Mexico Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Human Insulin Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Human Insulin Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Human Insulin Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Human Insulin Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Human Insulin Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Human Insulin Revenue Share by Country (2017-2028)
Figure 84. Turkey Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 87. Human Insulin Value Chain
Figure 88. Human Insulin Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Metformin Hydrochloride Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystall......

Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Antidiabetic Sulphonylureas market: According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......

Global Insulin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101

According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......

Global Insulin API Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period. The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......

Global Glucagon Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101

According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......

Global Acarbose Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period. The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......

Global Insulin Glargine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 77

According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......

Global Liraglutide Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 103

According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs